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Biomolecular Engineering, North Carolina State University, Raleigh, North CarolinaABSTRACT Protein aggregation is associated with fatal neurodegenerative diseases, including Alzheimer’s and Parkin-
son’s. Mapping out kinetics along the aggregation pathway could provide valuable insights into the mechanisms that drive
oligomerization and fibrillization, but that is beyond the current scope of computational research. Here we trace out the full
kinetics of the spontaneous formation of fibrils by 48 Ab16-22 peptides, following the trajectories in molecular detail from an
initial random configuration to a final configuration of twisted protofilaments with cross-b-structure. We accomplish this by per-
forming large-scale molecular-dynamics simulations based on an implicit-solvent, intermediate-resolution protein model,
PRIME20. Structural details such as the intersheet distance, perfectly antiparallel b-strands, and interdigitating side chains
analogous to a steric zipper interface are explained by and in agreement with experiment. Two characteristic fibrillization
mechanisms—nucleation/templated growth and oligomeric merging/structural rearrangement—emerge depending on the
temperature.INTRODUCTIONThe pathological hallmark of a number of neurodegenera-
tive diseases, including Alzheimer’s, Parkinson’s, and the
prion diseases, is the presence of self-assembled structures,
known as fibrils or amyloid (1–3). The central role of am-
yloid in the nearly 40 diseases that have been identified
thus far has prompted a massive amount of experimental
research over the last decade aimed at understanding protein
aggregation in general and fibril self-assembly in particular
(4–13). Such studies are increasingly being complemented
by atomistic-level simulations, which have the potential to
provide details about the aggregation process that cannot
be obtained directly from experiments. The huge computa-
tional demands associated with atomistic-resolution simula-
tions, however, restrict the types of studies that can be done
to simulations of the formation of small oligomers (14–20)
or analysis of the thermodynamic stability of expected fibril-
lar structures based on known experimental results (21–29).
Although coarse-grained models (30–36) do have the poten-
tial to analyze fibril formation and give kinetic insights,
they are limited in their ability to account for amino-acid
specificity, which is a handicap when examining therapeutic
strategies to counter or enhance protein aggregation. We
have been threading our way through the middle by per-
forming simulations at intermediate (as opposed to atom-
istic or coarse-grained) resolution (37,38). This allows usSubmitted June 30, 2011, and accepted for publication August 22, 2011.
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. Open access under CC BY-NC-ND license.to observe the full kinetics associated with the spontaneous
formation of protein aggregates while retaining the struc-
tural details and amino-acid specificity, which are vital for
a complete understanding of disease-related aggregation.
The model peptide chosen for this study is Ab16-22
(KLVFFAE), a fragment of b-amyloid (Ab), the 40- or 42-
residue peptide linked to Alzheimer’s disease. As one of
two centrally located hydrophobic stretches in Ab, Ab16-22
plays a critical role in driving the assembly of the entire
peptide into oligomers and fibrils (5,39). Ab16-22 is known
to form fibrillar structures by itself based on solid-state
NMR and x-ray experiments (40), but their precise structure
in terms of b-sheets stacking is unknown. Experiments and
many computational studies suggest that the orientation of
peptides within each sheet is antiparallel, and that between
the sheets is parallel (15,24). The mechanisms for b-sheet
stacking and the number of sheets per stack predicted by
all-atom stability simulations differ from study to study
(23–25). A steric zipper interface has been suggested for
Ab16-22, although the interdigitized pattern is not as well
defined as it is for the best-known steric zipper, GNNQQNY
(4,41). This is likely due to the lack of size and shape com-
plementarity between the small (ALA) and large (PHE) side
chains (23). Clearly, however, the number of sheets per
stack, the arrangement of side chains within the steric zip-
per, and the parallel or antiparallel arrangement of peptides
within and between the sheets are governed as much by
kinetics as by thermodynamics (stability).
In this work we present the results of large-scale, interme-
diate-resolution molecular-dynamics (MD) simulations of
the spontaneous formation of fibrils by a system containing
48 Ab16-22 peptides based on a new, to our knowledge,
implicit-solvent protein model, PRIME20 (see Methods).
We are able to trace out the aggregation process of a largedoi: 10.1016/j.bpj.2011.08.042
2494 Cheon et al.system of nontrivial peptides along the entire fibrillization
pathway, from an initial configuration of random coils to
twisted protofilaments with cross-b-structures, and to dem-
onstrate how the kinetics dictates both the fibrillization
process and the structural details of the fully formed fibril.FIGURE 1 Snapshots of DMD simulations for 48 Ab16-22 chains. Figures
were drawn with the use of the VMD program. (a) Starting configuration
(t* ¼ 508) at temperature T* ¼ 0.20 after 8.6 billion collisions in a slow
cooling simulation from T* ¼ 0.50 (t* ¼ 0). (b) A nucleation seed consist-
ing of a small bilayered cross-b-structure with four strands per sheet is
formed after 31 billion collisions (t* ¼ 1852). (c) The nucleation seed
has grown into a bilayered cross-b-structure after 44 billion collisions
(t*¼ 2586). (d) A third layer is formed as single peptides attach themselves
to the second layer one by one after 49 billion collisions (t* ¼ 2863). (e) A
three-layered b-sheet, essentially a protofilament, is grown after 63 billion
collisions (t* ¼ 3720) and remains stable until the end of the simulation
(f) at 213 billion collisions (t* ¼ 12,611).METHODS
PRIME20
We performed simulations by applying discontinuous MD (DMD) (42), a
very fast and efficient alternative to traditional MD, to proteins modeled
using PRIME20, an intermediate-resolution force field for proteins.
PRIME20 is an extension of PRIME, an intermediate-resolution protein
model (43) previously used in DMD simulations of the aggregation of poly-
alanine (37) and polyglutamine (38) to describe the geometry and ener-
getics of peptides containing all 20 amino-acid residues (44).
PRIME20 was designed to provide biophysical insights into protein
folding and aggregation, and is particularly useful for studying the behavior
of large systems of proteins over long timescales. Peptides are modeled
using a four-spheres-per-residue representation (backbone united atoms
NH, CaH, and CO, and a single sphere side chain). We assign mass to
each united atom as CaH (0.866), NH (0.999), CO (1.863), and side-chain
spheres K (4.865), L (3.799), V (2.866), F (6.061), A (1.000), E (4.793) in
mass units of CH3 (15 amu ¼ 1.0). Consequently, the procedures for esti-
mating the time to the next collision and the change in momentum after
events such as core collision, capture, dissociation, and bounce are modified.
In estimating pair interaction parameters, the 20 amino-acid side chains
are classified into 14 groups (LVI, M, F, Y, W, A, C, ED, KR, P, ST, QN,
H, and G) according to their hydrophobicity, polarity, size, charge, and
potential for side-chain hydrogen bonding. The 19 and 23 energy parameter
sets are obtained by applying a perceptron learning algorithmplus amodified
stochastic learning algorithm that optimizes the energy gap between 711
known native states from the PDB and decoy structures generated by gapless
threading based on the four-sphere representation (44). We used the 19
energy parameter set from Table 2 of Cheon et al. (44), in these simulations.
All pair interactions are represented in terms of reduced energies, ε*(ij) ¼
ε(ij)/εHB, where εHB is a hydrogen-bonding energy.
We keep the original PRIME backbone geometric parameters for the
NH(i)-Ca(i), Ca(i)-CO(i), CO(i)-NH(iþ1) covalent bond lengths, and for
the NH(i)-CO(i), Ca(i)-NH(iþ1), CO(i)-Ca(iþ1), and Ca(i)-Ca(iþ1)
pseudo-bond distances. However, the geometric distance parameters related
to the side-chain centroids are assigned separately for each amino acid, i,
including side-chain sphere diameters, side chain to Ca distances (Ri-Ca),
side chain to NH (Ri-NH) or CO distances (Ri-CO) (pseudo-bond lengths),
and local distances between backbone and side-chain spheres (squeeze
parameters). It is essential to have realistic values for all of the side-chain
distance parameters because these determine whether we have accurate
values of the van der Waals volume, backbone structures in agreement
with native PDBs, correct backbone dihedral angles, and L-isomerization
of amino acids. We initially attempted to evaluate average values for
Ri-Ca, Ri-NH, and Ri-CO for each amino acid by mining data on native
structures from the PDB. However, simple evaluations based on averages
of these distributions were not suitable because simulations using these
values gave improper backbone structures with wrong backbone dihedral
angles and ultimately no secondary structure. In addition, there was a
problem with L-form amino acids changing to D-form amino acids for large
amino acids. Such D-form amino acids distort backbone structures, allow-
ing all dihedral angles. The lesson we learned from these unsuccessful
efforts to estimate side-chain distance-related parameters from PDB distri-
butions is that those distances must be carefully adjusted to give allowed
dihedral angles and keep L-isomerization under the 2.3% bond tolerance.
We devised an alternate and ultimately successful approach in which we
determined the side-chain-related distance parameters using a trial andBiophysical Journal 101(10) 2493–2501error approach that involved performing DMD simulations with many
different sets of Ri-Ca, Ri-NH, and Ri-CO, and the squeeze distances.
The test cases were 12 different 11-residue poly-X peptides (where X stands
for each of the 20 possible amino acids modeled with the test geometry).
After a run of 20 billion collisions, we checked to ensure that the resulting
Ramachandran plots were consistent with known allowed angle regions.
The test values of the parameters for the poly-X peptides were chosen to
be within allowed distance values consistent with the 711 native PDB struc-
tures (all globular single-chain proteins without nucleic acids or ligands),
and also to prevent the occurrence of D-form amino acids. The Ca to
side-chain distances in the simulations reported here are 3.55 A˚ (K),
2.625 A˚ (L), 2.002 A˚ (V), 3.425 A˚ (F), 1.600 A˚ (A), and 3.180 A˚ (E).Simulation procedures
The simulations proceeded in the following way: We placed 48 peptides
in random locations and random coil conformations by performing DMD
simulations at high temperature. The temperature was then lowered continu-
ously from T* ¼ 0.50 to 0.20 over the course of 8.6 billion collisions
until t* ¼ 508, at which point the constant-temperature simulation began.
Extensive runs of up to 268 billion collisions (reduced time
t* ¼ t/s(kBT/m)1/2z16,000) were conducted at reduced temperatures rang-
ing from T* ¼ kBT/εHB ¼ 0.10 to 0.205, with periodic boundary conditions
at two different molar concentrations (c ¼ 10 mM with box size 200 A˚ and
~20 mM (19.46 mM) with box size 160 A˚). Ten independent runs at T*
near the transition temperature (above which fibrils do not form) at each con-
centration and five independent runs at lower temperatures were performed.RESULTS
Fibril growth from random initial configurations
Fig. 1 shows typical snapshots of fibril formation over the
course of the simulation at various reduced times t* for
FIGURE 2 Snapshots showing oligomer merging and fibril growth at low
temperature T*¼ 0.17. (a) Starting configuration (t*¼ 508) at temperature
T* ¼ 0.17 after 8.6 billion collisions in a slow cooling simulation from
T* ¼ 0.50 (t* ¼ 0). (b) Several nucleation seeds consisting of small
b-sheets and disordered aggregates after t* ¼ 1064. Oligomer merging
occurs between small oligomers after t* ¼ 1895 (c) and t* ¼ 2279 (d).
(e) Snapshot just before final merging into a large oligomer at t* ¼ 2563.
A variety of partially ordered structures appear, including a disordered
sheet-like structure (yellow), an annular b-barrel (green), and b-sheets
(purple, orange, and turquoise) at t* ¼ 2563. (f) Five-layer fibril structure
at t* ¼ 5198 after a long period of angular and structural rearrangements.
Formation of Ab16-22 Fibrils 2495simulations performed at high reduced temperature T* ¼
0.20. The starting configuration for the constant temperature
portion of the run (Fig. 1 a) is a random configuration of
random coils. As the simulation proceeds, a variety of struc-
tures (e.g., small disordered aggregates, single- and bilayer
b-sheets, annular b-barrel, and sandwiched b-sheets; see
Fig. S1 in the Supporting Material) continuously form and
dissolve, but none are capable of seeding the nucleation
process. After 23 billion collisions (the lag time for this
simulation), a stable fibril nucleus finally forms (Fig. 1 b),
consisting of a bilayer of b-sheets with four peptides per
sheet. Thereafter, the nucleus grows through 1), the one-
by-one addition of monomers to the ends of the first and
second sheets (Fig. 1 c) via random attachment and struc-
tural adjustment of monomers; and 2), the addition of a
few disordered peptides to the side of the bilayered surface,
which subsequently rearrange (Fig. 1 d) in a second nucle-
ation process to form a third layer. Fig. 1 e shows a stable
trilayered b-sheet surrounded by free monomers. Finally,
after very long simulation times (Fig. 1 f), a protofilament
containing three b-sheet layers of comparable lengths and
a few free monomers remain at equilibrium. We interpret
this sequence of events as a nucleated process followed by
templated assembly, meaning that soluble random-coil pep-
tides bind to a preassembled b-sheet-rich nucleus (45).
Qualitatively similar growth kinetics has also been observed
in a lattice toy model introduced by Li et al. (35).
In contrast to the sequence of events observed at high
temperature, fibril formation at low reduced temperatures
(T* ¼ 0.15–0.18) is not a simple nucleation and growth
process in which free monomer peptides attach themselves
to a nucleus one by one. Instead, the process involves hydro-
phobic collapse at an early stage, oligomeric merging of
partially ordered protofilaments at an intermediate stage,
and structural rearrangement at later times. Snapshots are
shown in Fig. 2. The random initial configuration (Fig. 2 a)
quickly evolves to a system of small oligomers (Fig. 2 b),
including a disordered oligomer (green) a single-layer
b-sheet (turquoise), a bilayer b-sheet (orange), and sand-
wiched bilayer b-sheets (purple). These merge and separate
from each other over time (Fig. 2, c and d). Fig. 2 e is a snap-
shot of two medium-size oligomers just before they merge
to form the final large oligomer; each contains ordered
and disordered regions, e.g., a disordered sheet-like struc-
ture (yellow) and an annular b-barrel (green) and b-sheets
(purple, orange, and turquoise). After this merging event
takes place, the large oligomer undergoes a complex struc-
tural reorganization that involves transformation of dis-
ordered sheet and b-barrel into cross-b-structures, and
angular rearrangement of the interface between the merging
structures. The final structure is a five-layer protofilament as
shown in Fig. 2 f. (Note that although we explain the kinetic
process from snapshots of a single run, similar characteristics
and patterns are observed for five different runs at each
temperature.)The differences between the kinetic aggregation mecha-
nisms at high temperature T* ¼ 0.20 and low temperature
T* ¼ 0.17 can be understood by reference to Fig. 3, which
shows how the following four observables evolve with time:
1), the average fraction of peptides that are in b-sheet con-
formations (the b-sheet content); 2), the average fraction of
peptides that are in disordered oligomers (disordered chain
content); 3), the average fraction of free monomers (free
monomer content); and 4), the orientational order parameter
defined by the average over the absolute values of the
cosines of the angles (< jcos qj >) between two interacting
peptides in a system. The angle q is the angle between two
interacting peptide vectors, where each peptide is repre-
sented by a vector from the position of the L17 Ca to the
position of the A21 Ca; thus, when q¼ 0 or 180 and hence
jcos qj ¼ 1, two peptide chains are parallel or antiparallel
and hence aligned. The points on Fig. 3 labeled by arrows
a–f correspond to the timeframes for the snapshots in
Figs. 1 and 2, a–f. The b-sheet, disordered chain, and free
monomer contents sum to 1.0. Fig. 3 a shows the b-sheet
and disordered chain content, and Fig. 3 b shows the free
monomer content and the orientational order parameter at
high temperature T* ¼ 0.2. Fig. 3, c and d, show the same
observables, but for low temperature T* ¼ 0.17.
The results presented in Fig. 3 give us a better sense of the
order in which the aggregation events take place at high
(T* ¼ 0.20) and low (T* ¼ 0.17) temperatures. At high
temperature, Fig. 3 a, the disordered chain content (red)
is sizeable at an early stage and slowly diminishes. The
b-sheet content (blue) grows slowly but does not convergeBiophysical Journal 101(10) 2493–2501
FIGURE 4 Final fibril structures observed at the end of simulations. (a)
CPK figure and (b) ribbon figure for bilayered fibril observed at T*¼ 0.197,
c¼ 10 mM. Side-chain spheres: K (blue), L (red), V (turquoise), F (pink), A
(orange), and E (yellow). Backbone spheres are colored green and magenta.
(c) Trilayered fibril observed at T*¼ 0.20 and c¼ 20 mM. (d) Four-layered
fibril obtained at T* ¼ 0.20, c ¼ 20 mM.
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FIGURE 3 Kinetic mechanisms as revealed by
the evolution of four observables with time. (a)
b-sheet content (blue) and disordered chain content
(red), and (b) free monomer content (green) and
orientational order parameter (violet) at high tem-
perature T* ¼ 0.20. The same four observables at
low temperature T* ¼ 0.17 are shown in c and d.
Arrows indicate times at which snapshots in Figs.
1 and 2 were taken.
2496 Cheon et al.to one; instead, a small fraction of the peptides remain as
free monomers (green), as shown in Fig. 3 b. The orientation
order parameter (violet) increases with time to its maximum
value at e, but the b-sheet content continues to increase even
after that. This implies that a medium-size protofilament
(the snapshot of Fig. 1 e) has an orientational order similar
to that of the large protofilament (the snapshot of Fig. 1 f.
Because the increase in b-sheet content from e to f corre-
sponds to the decrease in the free monomer fraction, this
implies that most free monomers attach to the preordered
template and rearrange very rapidly in an ordered pattern,
that is, without undergoing any significant structural rear-
rangement. At low temperature (Fig. 3 c), the disordered
chains also appear at an early stage. The fraction of free
monomers decreases to zero much faster than at high
temperatures, implying a rapid formation of oligomers.
The orientational order in Fig. 3 d show a plateau region
at modest values (lower than in Fig. 3 b) between 1000 <
t* <2500, which signals the presence of an oligomer
merging process between arrowed points b–e corresponding
to Fig. 2, b–e. In contrast to the behavior at high tempera-
ture, the orientational order at low temperature saturates
very slowly even after the b-sheet content has reached its
maximum value. Therefore, the structural rearrangement
that occurs before the formation of the final fibril structure at
low temperature appears to proceed by angular reorientation
of adjacent peptide vectors among nearby merging oligo-
mers. The differences between fibril formation at low and
high reduced temperatures can be also seen in the movie
files in the Supporting Material. A comparison of the kinetic
processes at different temperatures reveals that the fibrilliza-
tion kinetics is remarkably sensitive to outside conditions
such as temperature. The importance of temperature and
sequences in determining the fibrillization timescale wasBiophysical Journal 101(10) 2493–2501highlighted in a recent lattice-model-based study (36).
These findings suggest that assembly pathways differ from
protein to protein not only because of the difference in
sequence (18) but also because different parts of the temper-
ature range for fibrillization are being accessed.Multilayered protofilaments
Fig. 4 shows snapshots of some of the fibrils we observed at
the end of our high-temperature simulations. All are twisted
and contain two-, three-, and four-layer b-sheets. The actual
structure for KLVFFAE (bi-, tri-, or quad-layered) is un-
known, although a five-layer structure is suspected based
on microscopy images (24). X-ray scattering intensities
calculated for the bi- and trilayer structures with the use
of the CRYSOL program (46) are given in Fig. 5. The inter-
strand distances (4.77 and 4.8 A˚) and the trilayer intersheet
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FIGURE 6 Temperature dependence of structural and thermodynamic
properties. (a) Average percentage of peptides in b-sheets versus reduced
temperature. Error bars are maximum/minimum values among independent
runs. (b) The backbone hydrogen-bonding energy (blue), the pair interac-
Formation of Ab16-22 Fibrils 2497distances (9.77 A˚) are consistent with the real x-ray diffrac-
tion peaks 4.7 A˚ and 9.9 A˚ (24,40). The bilayer intersheet
distance is relatively high (11.1 A˚) compared with that for
the full fibrillar structure (9.9 A˚), suggesting that this may
be a function of the number of sheets. Ramachandran plots
for 47 trajectories during the final 10 billion collisions at
T ¼ 0.17 and 20 mM are given in Fig. S2 for each residue
from 17L to 21A without the N- and C-terminals. Rama-
chandran plots for 17L and 18V clearly show b-sheet
regions, whereas those for 21A show both high b-strand
populations and small a-helix-populations (the latter is
due to the relative flexibility of the alanine backbone and
the low mass of the alanine side-chain centroid). The angles
for 19F and 20F show broader distributions because they
have larger side chains and a longer Ca to side-chain cen-
troid distance in our united atom model. Overall, the Ram-
achandran plots indicate a clear preference for b-sheets,
which agrees with our observation of fibril structures. It is
also apparent that the values chosen in PRIME20 for the
sizes of the side-chain centroids, and the lengths of the
covalent bond and pseudo-bond for each amino acid are
consistent with the backbone structure and chirality
(L-isomerization) observed in nature.tion energy among side chains (red, a hydrophobic energy), and the total
potential energy (green) in the system obtained at various temperatures.
(c and d) Percentage of parallel (red squares) and antiparallel (blue dia-
mond) neighboring strands within a sheet at various temperatures at (c)
c ¼ 20 mM and (d) c ¼ 10 mM.
Temperature dependence of fibril formation
The b-sheet content over 5 or 10 runs is plotted in Fig. 6 a
versus reduced temperature for peptide concentrations (c ¼
10 mM and 20 mM). The b-sheet content (a proxy here for
fibrillar content) at T* ¼ 0.20 (c ¼ 10 mM) and T* ¼ 0.205
(c ¼ 20 mM) is very low (0.05%), indicating that these are
slightly above the transition temperature for fibril formation,
the highest temperature at which fibrils are observed. Above
the transition temperature, the system remains a collection
of random coils. The relatively sharp transition (T* ¼
0.20–0.205) as a function of temperature is a consequence
of the nucleation process by which the ordered oligomers
are formed, i.e., at the transition temperature, the peptides
can be in one of two states: random monomers or the
ordered template. The final structures from 10 independent0 0.5 1 1.5 2
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FIGURE 5 Small angle x-ray scattering intensities for simulated fibrils in
this work over (a) 301 bilayer and (b) 224 trilayer trajectories at later times.
Because Q ¼ 4p sin q=l ¼ 2p=d, the peak positions correspond to 11.1 A˚,
4.77 A˚ for bilayer, and 19.5 A˚, 9.77 A˚, and 4.80 A˚ for trilayer.runs at T* ¼ 0.197, c ¼ 10 mM yield seven bilayered and
three trilayered b-sheets. A snapshot of one of the seven
bilayers is shown in Fig. 4, a and b. The final structures
from 10 independent runs at T* ¼ 0.20, c ¼ 20 mM yield
eight trilayered structures (e.g., Fig. 4 c) and two four-
layered b-sheets (e.g., Fig. 4 d). Thus, the number of b-sheet
layers increases as the concentration increases.Exposed hydrophobic residues at very low
temperatures
As shown clearly in Fig. 6 a, the aggregates observed at very
low temperature are disordered, as reflected in the low
b-sheet content at very low temperature (T* ¼ 0.10–0.12).
These aggregates remain frozen at such low temperatures
and do not transform to ordered b-sheets even for very
long runs. As shown in Fig. 6 b, the backbone hydrogen-
bonding energy (blue) at these conditions is comparable to
the side-chain pair interaction energy (red). At higher tem-
peratures (T* ¼ 0.15–0.17), where we see ordered protofila-
ments, the balance between the two types of energy shifts,
with the hydrogen-bonding energy becoming more negative
and the side-chain pair interaction energy becoming less
negative, even though the total potential energy (green) is
relatively unchanged. A comparison of the low-temperature
regions, where we have disordered aggregates, and theBiophysical Journal 101(10) 2493–2501
2498 Cheon et al.high-temperature regions, where we have ordered fibrillar
structure, indicates the somewhat surprising result that the
hydrophobic residues are more exposed in protofilament
structures than in fully disordered oligomers. This suggests
that the toxicity of the early b-sheet-rich oligomers that
form in some amyloid diseases may be due to an excess
of exposed hydrophobic residues (18).Antiparallel fibrils at high temperature
The probabilities of having parallel (angle q< 60) and anti-
parallel (angle q > 120) strands within the same sheet are
shown in Fig. 6, c and d. Antiparallel b-sheets are observed
with high probability at high temperatures such as T* ¼
0.20 (and c ¼ 20 mM), which is near the transition temper-
ature for fibrillization. Perfectly antiparallel b-sheet struc-
tures are sometimes seen at these conditions. An example
of a perfectly antiparallel trilayer protofilament (except for
the flexible ends) is shown in Fig. 4 c. The evolution from
a mixed parallel/antiparallel fibril to a perfectly antiparallel
fibril can be seen in the snapshots presented in Fig. 7.
Parallel strands that formed early in the simulation switch
to an antiparallel orientation by a continuous stochastic pro-
cess. The switch occurs most often on the outside surfaces
of a fibril or at the sheet ends when a misaligned strand
moves away from the fibril, changes its orientation, and
then reattaches. This detachment and reattachment process
is most likely to occur at T* near the fibrillization transitionFIGURE 7 Snapshots describing the thermal fluctuation-induced switch-
ing of strands from parallel to antiparallel configurations within the ordered
b-sheets in Fig. 1. Conformations at the cross-b-edge at (a) 42.7, (b) 43.6,
(c) 43.8, (d) 44.1, (e) 44.4, (f) 44.5, (g) 44.7, (h) 45.0, and and (i) 63.6
billion collisions are shown. Red and green strands in the upper sheet,
which are parallel in a, move to a lower sheet by e. Blue and violet strands
remain parallel in the upper sheet from a to e. The green strand detaches
from the fibril in f and the violet strand moves to the side of the upper
b-sheet in g. The red strand moves back to the upper sheet in f and reat-
taches, but now next to the blue strand in an antiparallel configuration.
The red and blue strands remain antiparallel from h to i. (i) The green
and violet strands are now antiparallel in the lower b-sheet, and the switch
from parallel to antiparallel strands is completed.
Biophysical Journal 101(10) 2493–2501temperature when the chains have sufficient (but not too
much) kinetic energy to overcome the potential energy
that holds the fibril together. This explains why perfect anti-
parallel structures are most likely to be created at these
temperatures.
The fibrillar structures we observed in our simulations
exhibit a twist whose degree decreases as the number of
b-sheet layers increases, as can be seen by examining the
trends in Fig. 4. For example, the bilayered b-sheets in
Fig. 4 b exhibit the most twist. Fig. S3 shows distributions
of the angle between neighboring strands on a b-sheet. The
decrease in twist with increasing number of layers is consis-
tent with the recent experimental microscopy image for
b-lactoglobulin fibrils showing multistranded helical fibrils
whose pitch depends on the number of b-sheet layers (47).Positions of side-chain centroids and the steric
zipper interface
An analysis of the positions of side-chain centroids when the
protofilaments are perfectly antiparallel shows that side
chains L17, F19, and A21 are on the inside of the bilayered
structure (between the sheets) shown in Fig. 8 a, whereas
side chains K16, V18, F20, and E22 are on the outside.
This type of structure is similar to the so-called steric-zipper
interface in the cross-b-spines observed for GNNQQNY by
the Eisenberg group (4,41). Thus, even though our side
chains are represented rather simply by a single sphere,
and the peptide assembly process is kinetic, the fibrils that
form spontaneously in our simulations exhibit interdigitized
side-chain steric zipper patterns within a well-ordered anti-
parallel fibril structure. Having residues L17, F19, and A21
reside on the inside of the bilayer is consistent with the
following atomistic stability simulation results obtained
for KLVFFAE: the lowest-energy conformation, PARLFA,
found by Ro¨hrig et al. (23); the second-lowest bindingFIGURE 8 Views down the fibril axis of twisted b-sheets, showing only
eight strands per sheet taken from middle of fibrillar sheets in Fig. 2,
b and c. Backbone NH, CO, and CaH are reduced in size for ease of
viewing. Large spheres representing side-chain centroids are scaled accord-
ing to side-chain sizes. (a) Bilayered fibril obtained at T* ¼ 0.197, c ¼
10 mM. (b) Trilayered fibril at T* ¼ 0.20, c ¼ 20 mM. Side chains for
K16, V18, F20, and E22 are all colored red. Side chains for L17, F19,
and A21 are colored as follows: blue for right (green) sheet, turquoise for
middle (magenta) sheet, and yellow for left (blue) sheet. (c) Trilayer fibril
structure showing locations of individual side chains: K (blue), L (red),
V (turquoise), F19 (pink), F20 (mauve), A (orange), and E (yellow).
Formation of Ab16-22 Fibrils 2499free-energy conformation, AregBB, found by Park et al.
(25); and the bilayered model structure used by Krone
et al. (26).
The steric zipper interfaces for the tri- and quad-layer
b-sheet structures that formed in our simulations are more
complex than those in the bilayer. Fig. 8, b and c, show
the structure of the ordered trilayer and the positions of
the side chains at a temperature slightly below the transition
temperature. This structure evolves over the course of the
simulation in the following way: The bilayered cross-b-
sheet assembles early in the simulation, adopting a confor-
mation that is stabilized by interdigitation of amino acids
L17, F19, and A21 (see Fig. 8 a). The third b-sheet (blue
backbone and yellow side chains) grows onto the preexisting
bilayer by forming a steric zipper in which side chains L17,
F19, and A21 on the new (third) b-sheet interdigitize with
the outside side chains K16, V18, F20, and E22 on the
already formed bilayer. This interface pattern is in agree-
ment with PARmixed (23) and AregFB (25), which was
shown to be stable in atomistic simulations. It is the only
interface pattern that is capable of forming periodic stacks,
and is an example of a class 6 steric zipper (antiparallel,
face-to-back, up ¼ down) according to the classification
of Sawaya et al. (41). It is also consistent with the interface
pattern suggested by Mehta et al. (24), who considered five-
layer periodic structures. The type of b-sheet stack we saw
at the end of our simulations is very much a consequence of
kinetic processes, and as such is different from the other
periodic or laminated stacks found in atomistic stability
simulations (23–25).DISCUSSION AND CONCLUSION
The great strength of our computational approach—its
ability to trace out the molecular motions of a large sys-
tem of nontrivial peptides along the entire fibrillization
pathway—is tempered by some weaknesses and cautions
having to do with how faithfully this coarse-grained model
represents real experiments in vitro or even all-atom simula-
tions. Obviously, our model peptides easily form the back-
bone hydrogen bonds that are necessary to create b-sheets
when the thermal excitations are sufficient to overcome
hydrophobic free-energy trapping in rather amorphous ag-
gregates. This is an advantage of our approach, but it does
make it more difficult under low thermal fluctuations to ex-
amine transitions from disordered aggregates to ordered
structures. This is due in part to our use of a square-well
potential and simple side-chain geometry, which makes it
harder for the aggregates in meta-stable states to overcome
the energetic barriers by making very small consecutive
modifications on the way to the global ordered structure.
Although having a single-sphere side chain is an asset in
terms of having a fast code, and is good enough for small
hydrophobic residues such as alanine or valine, it is a lia-
bility when representing large aromatic residues such as F,Y, and W. This is because we are unable to describe the
p-p interactions between rings, which require information
on the rotational conformation of the side chains. Conse-
quently, shape complementarity between sheets is not as
well described as it might be. The single-sphere side chain
also makes it harder to model the behavior of polar side
chains such as Q and N, which are important in the prion
sequences (4,48), because we cannot easily represent side-
chain to side-chain hydrogen bonding, a directional poten-
tial. Having a single-sphere side chain makes it harder
to accurately represent salt bridge interactions between
charged side chains, an interaction that is known to play a
key role in Ab42 amyloid fibril formation. Therefore, at pre-
sent, it is not easy to apply our model to full-length Ab40 or
Ab42, which is our ultimate objective and a tremendous
challenge. We are now working to extend our model to have
multibead side chains and a more elaborate potential so as
to simulate the aggregation of longer and more-realistic
peptides. The key here is to include only those refinements
that are essential; adding in too much detail will slow down
the code to the point where wewill be unable to observe fibril
formation.
One of the most promising and thought-provoking results
from these simulations is our observation of perfect anti-
parallel b-sheets at high temperatures, besides the mixed
parallel/antiparallel b-sheets observed at low temperature.
The promise, of course, stems from the fact that this is con-
sistent with experiments and stability studies. It is thought-
provoking because of our general observation that it can
be difficult to determine which state (parallel, antiparallel,
or mixed) is the true equilibrium state, both in simula-
tions starting from random configurations (16,20,49) and
in well-ordered atomistic stability simulations (50), because
the free-energy difference between candidate equilibrium
states can be quite small.
In summary, we performed large-scale, intermediate-
resolution MD simulations of the spontaneous formation
of fibrils by a system containing 48 Ab16-22 peptides. We
accomplished this by applying DMD to PRIME20, an
implicit solvent protein model that is applicable to all 20
amino acids (44). This is the first time, to our knowledge,
that the aggregation process for a very large system (48
peptides) of nontrivial peptides (Ab16-22) has been mapped
out along the entire fibrillization pathway, from an initial
configuration of random coils to twisted protofilaments
with registered b-sheets and cross-b-structures. Our simula-
tions provide molecular-level insights into how the evo-
lution of the assembly process over time influences the
nature of the final fibrillar structure. We observed two types
of fibrillization mechanisms depending on the temperature,
namely, nucleation/templated growth at and near a transition
temperature above which fibrils do not form, and an oligo-
meric merging/structural rearrangement at lower tempera-
tures similar to the nucleated conformational conversion
mechanism. The positions of the side-chain centroids inBiophysical Journal 101(10) 2493–2501
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and delineate the steric zipper pattern observed by the
Eisenberg group (4,41) for GNNQQNY, even though our
one-bead side-chain model does not allow for a detailed
representation of shape complementarity. Most of the struc-
tural details observed in experiments (24,39) and stability
simulations (23–26), including multilayered fibrils with
perfectly antiparallel b-strands that are in-register and con-
tain a regular twist, a coherent steric zipper interface, and
interstrand and intersheet distance, are well captured. Our
success in mapping out the predominant kinetics and the
structural characteristics for twisted protofilaments with
cross-b-structure for a system of 48 Ab16-22 peptides, and
in generating a computational realization of spontaneous
formation of fibrils along the entire fibrillization pathway
demonstrates the potential usefulness of the DMD/
PRIME20 approach. Other recent successes achieved with
intermediate-resolution models include the PROFASI-
model-based observation by Li et al. (20) of medium-sized
(24-peptide) protofilaments for the amyloid t fragment
VQIVYK using Monte Carlo simulation. All of these efforts
bring us one step closer to being able to make a genuine con-
tribution to the amyloid field, and in particular to develop
therapeutic strategies to treat the amyloid diseases.SUPPORTING MATERIAL
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